M K King
Overview
Explore the profile of M K King including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
King M, Jope R
Genes Brain Behav
. 2013 Aug;
12(7):723-31.
PMID: 23941202
Fragile X syndrome (FXS) is caused by suppressed expression of fragile X mental retardation protein (FMRP), which results in intellectual disability accompanied by many variably manifested characteristics, such as hyperactivity,...
2.
3.
4.
5.
Davis L, Eisen S, Murphy F, Alpern R, Parks B, Blanchard M, et al.
Neurology
. 2004 Sep;
63(6):1070-7.
PMID: 15452300
Background: The prevalence of symptoms suggesting distal symmetric polyneuropathy (DSP) was reported to be higher among deployed veterans (DV) to the Persian Gulf in 1990-1991 than to control non-deployed veterans...
6.
Multani M, Krombach R, Goldberg A, King M, HENDRICK J, SAMPLE J, et al.
J Cardiovasc Pharmacol Ther
. 2002 Mar;
6(4):369-76.
PMID: 11907639
Background: The present study examined the effects of acute angiotensin-converting enzyme inhibition (ACEI), AT(1) receptor blockade (AT(1) block), or combined treatment on in vitro and in vivo bradykinin (BK) levels....
7.
Becher M, Morrison L, Davis L, Maki W, King M, BICKNELL J, et al.
JAMA
. 2001 Dec;
286(19):2437-40.
PMID: 11712939
Context: Oculopharyngeal muscular dystrophy (OPMD) is a rare myopathy caused by polyalanine triplet repeat expansion in the gene for poly(A) binding protein 2 (PABP2) and is found in isolated cohorts...
8.
McElmurray J, Mukherjee R, Patterson T, GOLDBERG A, King M, HENDRICK J, et al.
J Card Fail
. 2001 Jun;
7(2):158-64.
PMID: 11420768
Background: Past studies have suggested that amlodipine, a dihydropyridine L-type Ca(2+) channel antagonist, may exert useful effects in congestive heart failure (CHF). The present study examined the effects of amlodipine...
9.
Ergul A, Grubbs A, Zhang Y, Joffs C, SAMPLE J, King M, et al.
J Card Fail
. 2001 Mar;
7(1):84-91.
PMID: 11264554
Background: Although reduced pulmonary clearance of endothelin-1 (ET-1) has been suggested to contribute to increased circulating levels in congestive heart failure (CHF), the regulation of the pulmonary ET system with...
10.
King M, Gay D, Pan L, McElmurray 3rd J, HENDRICK J, Pirie C, et al.
Circulation
. 2001 Feb;
103(2):308-13.
PMID: 11208694
Background: Exogenous administration of growth hormone (GH) and subsequently increased production of insulin-like growth factor-1 can influence left ventricular (LV) myocardial growth and geometry in the setting of congestive heart...